Earnings History Data for Sierra Oncology, Inc. (SRRA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Sierra Oncology, Inc.

Sierra Oncology, Inc. is a clinical-stage drug development company. It develops and markets drugs for the treatment of cancer. The product pipeline consists of SRA737 and SRA141. SRA737 is an orally bioavailable small molecule inhibitor of Checkpoint kinase 1, a key cell cycle checkpoint and central regulator of the DNA Damage Response network. SRA141 is an orally available small molecule inhibitor of cell division cycle 7kinase. Sierra Oncology, Inc., formerly known as ProNAi Therapeutics, Inc., is headquatered in Vancouver, Canada.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
05-11-2021 PM SRRA Sierra Oncology, Inc. 302.18 -2.10 -1.78 -1.39 Sierra Oncology EPS beats by $0.02
[11/5/2021 9:01 AM]
23.03 0.74 
(3.30%)
0.0 0.0 
(0.00%)
13.32 - 23.85 20,744 30,000 0
07-05-2021 PM SRRA Sierra Oncology, Inc. 237.12 -1.71 -1.61 -1.31 Sierra Oncology EPS misses by $0.11
[5/7/2021 7:41 AM]
18.87 0.32 
(1.73%)
0.0 0.0 
(0.00%)
10.02 - 20.43 4,974 0 0
11-03-2021 PM 7:00 AM ET
(Mar 11)
SRRA Sierra Oncology, Inc. 166.00 -1.63 -1.55 0.00 Sierra Oncology EPS misses by $0.11
[3/11/2021 7:26 AM]
16.50 0.78 
(4.96%)
0.0 0.0 
(0.00%)
8.54 - 16.92 296,711 23,056 0